Class 1 Recall Issued by FDA Over Medtronic Faulty Cardiac Guidewires

Medtronic, Inc. initially began notifying hospitals and distributors worldwide in October 2013 that some models of its guidewires used in cardiac procedures could lose the coating on their surface resulting in the detachment and delaminating of the guidewires.  If the guidewires fail during or after the procedure, serious injury or death to the patient can [...]

November 21st, 2013|Drug and Medical Device Litigation|0 Comments

Whistleblowers, Undercover Employees Wearing Wires Led To Johnson & Johnson’s Guilty Plea Involving Risperdal

As reported earlier, Johnson & Johnson will pay $2.2 billion due to its practices of improper marketing and failure to warn.  Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, admitted that it promoted Risperdal to health care providers for treatment of psychotic symptoms and associated behavioral disturbances exhibited by elderly, non-schizophrenic dementia patients. More facts [...]

November 12th, 2013|Drug and Medical Device Litigation|0 Comments